Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK LIFE SCIENCES vs LUPIN - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GLENMARK LIFE SCIENCES LUPIN GLENMARK LIFE SCIENCES/
LUPIN
 
P/E (TTM) x 18.3 40.7 44.9% View Chart
P/BV x 4.5 6.0 74.5% View Chart
Dividend Yield % 2.7 0.2 1,095.5%  

Financials

 GLENMARK LIFE SCIENCES   LUPIN
EQUITY SHARE DATA
    GLENMARK LIFE SCIENCES
Mar-23
LUPIN
Mar-23
GLENMARK LIFE SCIENCES/
LUPIN
5-Yr Chart
Click to enlarge
High Rs534799 66.8%   
Low Rs369583 63.3%   
Sales per share (Unadj.) Rs176.4365.8 48.2%  
Earnings per share (Unadj.) Rs38.19.8 387.3%  
Cash flow per share (Unadj.) Rs41.529.2 142.3%  
Dividends per share (Unadj.) Rs21.004.00 525.0%  
Avg Dividend yield %4.70.6 803.5%  
Book value per share (Unadj.) Rs174.0270.7 64.3%  
Shares outstanding (eoy) m122.53454.98 26.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.61.9 135.5%   
Avg P/E ratio x11.870.2 16.9%  
P/CF ratio (eoy) x10.923.7 45.9%  
Price / Book Value ratio x2.62.6 101.7%  
Dividend payout %55.140.7 135.5%   
Avg Mkt Cap Rs m55,321314,381 17.6%   
No. of employees `000NANA-   
Total wages/salary Rs m1,80230,872 5.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m21,612166,417 13.0%  
Other income Rs m2901,509 19.2%   
Total revenues Rs m21,902167,926 13.0%   
Gross profit Rs m6,42317,206 37.3%  
Depreciation Rs m4218,807 4.8%   
Interest Rs m52,743 0.2%   
Profit before tax Rs m6,2867,165 87.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6162,688 60.1%   
Profit after tax Rs m4,6704,477 104.3%  
Gross profit margin %29.710.3 287.4%  
Effective tax rate %25.737.5 68.5%   
Net profit margin %21.62.7 803.2%  
BALANCE SHEET DATA
Current assets Rs m23,687124,513 19.0%   
Current liabilities Rs m10,22892,654 11.0%   
Net working cap to sales %62.319.1 325.3%  
Current ratio x2.31.3 172.3%  
Inventory Days Days226 6.2%  
Debtors Days Days13698 138.6%  
Net fixed assets Rs m8,518103,490 8.2%   
Share capital Rs m245910 26.9%   
"Free" reserves Rs m21,070122,246 17.2%   
Net worth Rs m21,315123,156 17.3%   
Long term debt Rs m0275 0.0%   
Total assets Rs m32,205228,003 14.1%  
Interest coverage x1,150.23.6 31,843.1%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.70.7 91.9%   
Return on assets %14.53.2 458.4%  
Return on equity %21.93.6 602.7%  
Return on capital %29.58.0 367.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,69148,057 20.2%   
Fx outflow Rs m5,00121,752 23.0%   
Net fx Rs m4,68926,306 17.8%   
CASH FLOW
From Operations Rs m3,13418,972 16.5%  
From Investments Rs m-1,541-12,868 12.0%  
From Financial Activity Rs m-3,876-3,373 114.9%  
Net Cashflow Rs m-2,2832,732 -83.6%  

Share Holding

Indian Promoters % 82.9 46.8 177.2%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 5.3 45.8 11.6%  
FIIs % 4.6 16.1 28.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.2 53.0 32.4%  
Shareholders   185,531 281,542 65.9%  
Pledged promoter(s) holding % 9.5 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GLENMARK LIFE SCIENCES With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GLENMARK LIFE SCIENCES vs Lupin

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GLENMARK LIFE SCIENCES vs Lupin Share Price Performance

Period GLENMARK LIFE SCIENCES Lupin S&P BSE HEALTHCARE
1-Day 0.01% 1.23% 1.18%
1-Month -11.59% 0.15% -0.75%
1-Year 106.25% 151.14% 61.82%
3-Year CAGR 1.19% 17.13% 18.16%
5-Year CAGR 0.71% 17.42% 19.79%

* Compound Annual Growth Rate

Here are more details on the GLENMARK LIFE SCIENCES share price and the Lupin share price.

Moving on to shareholding structures...

The promoters of GLENMARK LIFE SCIENCES hold a 82.9% stake in the company. In case of Lupin the stake stands at 47.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GLENMARK LIFE SCIENCES and the shareholding pattern of Lupin.

Finally, a word on dividends...

In the most recent financial year, GLENMARK LIFE SCIENCES paid a dividend of Rs 21.0 per share. This amounted to a Dividend Payout ratio of 55.1%.

Lupin paid Rs 4.0, and its dividend payout ratio stood at 40.7%.

You may visit here to review the dividend history of GLENMARK LIFE SCIENCES, and the dividend history of Lupin.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.